Drug intelligence / Profile preview

dobesilic acid

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Dobesilic acid is an organic compound classified as both a phenol and a sulfonic acid, with the molecular formula C6H6O5S. It serves as the parent compound for several pharmaceutical salts. The most clinically relevant derivative is calcium dobesilate, which acts as a vasoprotective agent used in the treatment of chronic venous disease, diabetic retinopathy, hemorrhoidal disease, and other microangiopathies. Dobesilic acid and its salts work primarily by reducing capillary permeability through stabilization of collagen chains in the basement membrane of blood vessels and interaction with biochemical mediators that regulate endothelial permeability. This leads to improved microcirculatory function, reduced blood hyperviscosity, and anti-platelet aggregation effects. The drug is generally well absorbed orally (as calcium dobesilate), has low plasma protein binding, minimal metabolism (<10%), and is mainly excreted renally.

Other names
2,5-dihydroxybenzenesulfonic acid
02

Targets

COL4 (Collagen IV)

Beyond the preview

Go deeper on dobesilic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dobesilic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call